Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a global pharmaceutical company that develops, manufactures, and markets a wide range of drugs and vaccines. It was founded in 1891 by George Merck and is headquartered in Kenilworth, New Jersey. The company is known for its innovative research and development and has a strong commitment to corporate social responsibility.
Company Info
US58933Y1055
58933Y105
Jan 13, 1978
Highlights
$249.37B
$4.78
20.62
0.07
$63.22B
$48.80B
$18.85B
$97.22 - $133.74
$133.43
1.03%
2.71
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Merck & Co., Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Merck & Co., Inc. had a return of -10.38% year-to-date (YTD) and -3.28% in the last 12 months. Over the past 10 years, Merck & Co., Inc. had an annualized return of 8.68%, while the S&P 500 had an annualized return of 11.16%, indicating that Merck & Co., Inc. did not perform as well as the benchmark.
MRK
-10.38%
-11.80%
-25.99%
-3.28%
6.70%
8.68%
^GSPC (Benchmark)
23.62%
0.54%
11.19%
30.63%
13.61%
11.16%
Monthly Returns
The table below presents the monthly returns of MRK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 10.79% | 5.27% | 4.43% | -2.07% | -2.85% | -0.80% | -8.62% | 4.70% | -3.49% | -9.90% | -10.38% | ||
| 2023 | -3.19% | -1.09% | 0.84% | 8.53% | -4.38% | 5.21% | -7.57% | 2.18% | -4.89% | -0.24% | -0.21% | 7.15% | 1.01% |
| 2022 | 6.32% | -6.01% | 8.10% | 8.09% | 3.77% | -0.12% | -2.01% | -4.45% | 1.70% | 17.51% | 8.81% | 1.42% | 49.42% |
| 2021 | -5.78% | -5.77% | 7.09% | -3.36% | 1.87% | 8.32% | -1.16% | -0.75% | -0.66% | 17.23% | -14.92% | 3.28% | 1.75% |
| 2020 | -6.06% | -10.39% | 1.33% | 3.12% | 1.74% | -3.44% | 3.76% | 6.27% | -2.01% | -9.33% | 6.89% | 2.56% | -7.21% |
| 2019 | -2.59% | 9.22% | 3.01% | -5.36% | 0.64% | 6.56% | -1.03% | 4.19% | -2.00% | 2.95% | 0.60% | 5.04% | 22.27% |
| 2018 | 5.30% | -8.49% | 1.34% | 8.08% | 1.12% | 2.75% | 8.52% | 4.13% | 4.13% | 3.76% | 7.78% | -3.02% | 39.95% |
| 2017 | 5.30% | 6.26% | -2.84% | -1.90% | 4.46% | -0.84% | -0.33% | -0.03% | 0.99% | -13.96% | 0.33% | 2.67% | -1.49% |
| 2016 | -4.07% | -0.91% | 6.30% | 3.65% | 2.59% | 3.23% | 1.82% | 7.04% | 0.12% | -5.91% | 4.21% | -3.05% | 15.05% |
| 2015 | 6.15% | -2.89% | -1.02% | 3.62% | 2.23% | -5.79% | 3.57% | -8.67% | -7.49% | 10.67% | -3.02% | 0.50% | -3.89% |
| 2014 | 5.83% | 7.59% | 0.39% | 3.15% | -1.20% | 0.74% | -1.92% | 5.94% | -0.66% | -2.26% | 4.25% | -5.27% | 16.93% |
| 2013 | 5.64% | -1.20% | 4.44% | 6.33% | -0.64% | 0.38% | 3.70% | -1.83% | 1.58% | -5.29% | 10.51% | 1.35% | 26.82% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of MRK is 32, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Merck & Co., Inc. provided a 3.21% dividend yield over the last twelve months, with an annual payout of $3.08 per share. The company has been increasing its dividends for 19 consecutive years.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $3.08 | $2.96 | $2.80 | $2.61 | $2.37 | $2.16 | $1.90 | $1.80 | $1.77 | $1.73 | $1.69 | $1.65 |
Dividend yield | 3.21% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% | 3.46% |
Monthly Dividends
The table displays the monthly dividend distributions for Merck & Co., Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.77 | $0.00 | $0.00 | $0.77 | $0.00 | $0.00 | $0.77 | $0.00 | $0.00 | $2.31 | |
| 2023 | $0.00 | $0.00 | $0.73 | $0.00 | $0.00 | $0.73 | $0.00 | $0.00 | $0.73 | $0.00 | $0.00 | $0.77 | $2.96 |
| 2022 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.73 | $2.80 |
| 2021 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.69 | $2.61 |
| 2020 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.58 | $0.00 | $0.00 | $0.62 | $2.37 |
| 2019 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.58 | $2.16 |
| 2018 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.46 | $0.00 | $0.00 | $0.52 | $1.90 |
| 2017 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.46 | $1.80 |
| 2016 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.45 | $1.77 |
| 2015 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.44 | $1.73 |
| 2014 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.43 | $1.69 |
| 2013 | $0.41 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.42 | $1.65 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Merck & Co., Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Merck & Co., Inc. was 68.63%, occurring on Mar 9, 2009. Recovery took 1239 trading sessions.
The current Merck & Co., Inc. drawdown is 27.41%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -68.63% | Dec 29, 2000 | 2057 | Mar 9, 2009 | 1239 | Feb 7, 2014 | 3296 |
| -47.25% | Jan 6, 1992 | 408 | Aug 13, 1993 | 494 | Jul 28, 1995 | 902 |
| -36.5% | Mar 23, 1999 | 243 | Mar 7, 2000 | 160 | Oct 23, 2000 | 403 |
| -35.03% | Jun 10, 1981 | 299 | Aug 13, 1982 | 236 | Jul 20, 1983 | 535 |
| -32.79% | Sep 4, 1987 | 95 | Jan 20, 1988 | 332 | May 12, 1989 | 427 |
Volatility
Volatility Chart
The current Merck & Co., Inc. volatility is 5.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Merck & Co., Inc. compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for MRK in comparison to other companies of the Drug Manufacturers - General industry. Currently, MRK has a PE value of 20.6. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for MRK in comparison to other companies of the Drug Manufacturers - General industry. Currently, MRK has a PEG value of 0.1. This PEG value is considered to be low compared to the rest of the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Merck & Co., Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |